George, Jessica A <br/><br/>
SRC tyrosine kinase and multidrug resistance protein-1 inhibitions act independently but cooperatively to restore paclitaxel sensitivity to paclitaxel-resistant ovarian cancer cells.  [electronic resource] 

 -  Cancer research  Nov 2005 
 - 10381-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-05-1822  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--antagonists & inhibitors<br/>Animals<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm<br/>Drug Synergism<br/>Female<br/>Humans<br/>Mice<br/>Microtubules--drug effects<br/>Ovarian Neoplasms--drug therapy<br/>Paclitaxel--pharmacology<br/>Protein Isoforms<br/>Tubulin--biosynthesis<br/>Up-Regulation<br/>src-Family Kinases--antagonists & inhibitors